Researchers from TGen, part of City of Hope, and from the University of California, San Diego have identified a set of genes that helps predict whether a patient's glioblastoma might respond to some promising drugs called ...
Jul 10, 2024
0
14
A new approach to treating the most malignant type of brain cancer—glioblastoma—has shown strong promise in pre-clinical settings, raising hopes of increasing current average survival rates beyond 18 months.
Jul 9, 2024
0
1
Every two days, Lynn Oxenberg leans over her bathroom sink while her husband shaves the shadow of auburn hair beginning to cover her head.
Jul 5, 2024
0
0
The cells of a rare, deadly cancer are resistant to immunotherapy. Now researchers may have found the cause, paving the way for a new type of treatment.
Jun 20, 2024
0
15
Investigators from Northwestern University Feinberg School of Medicine and The University of Texas MD Anderson Cancer Center have discovered that using a novel drug to target the STING pathway in glioblastoma reprogrammed ...
Jun 18, 2024
0
6
Glioblastoma multiforme (GBM) is among the most aggressive forms of brain tumors, with few effective treatment options and a bleak prognosis. The current standard of care (SOC), known as the STUPP regimen, includes surgical ...
Jun 12, 2024
0
1
In a major advance for the treatment of the deadly brain cancer glioblastoma, Northwestern Medicine scientists have used ultrasound technology to penetrate the blood-brain barrier and provide a small dose of a chemotherapy ...
Jun 6, 2024
0
83
Preliminary clinical data for glioblastoma multiforme patients enrolled in a Phase 1 clinical trial at the University of Alabama at Birmingham demonstrated that 92% of evaluable patients treated with INB-200 exceeded a median ...
Jun 5, 2024
0
0
In a new study, Yale researchers describe how a novel chemical compound attacks drug-resistant brain tumors without harming healthy surrounding tissue.
Jun 3, 2024
0
28
For many patients with a deadly type of brain cancer called glioblastoma, chemotherapy resistance is a big problem.
May 20, 2024
0
22
